31 results
6-K
NCNA
NuCana plc
16 Apr 24
NuCana Announces Completion of ADS Ratio Change
8:08am
affect the Company’s business, strategy, operations, or financial performance, and inherently involve significant known and unknown risks
6-K
NCNA
NuCana plc
27 Mar 24
NuCana Announces Plan to Implement ADS Ratio Change
4:39pm
and expectations of future events and trends, which affect or may affect the Company’s business, strategy, operations, or financial performance, and inherently
6-K
EX-99.3
NCNA
NuCana plc
17 May 23
Unaudited Condensed Consolidated Statements of Operations
4:07pm
highlighting its multi-faceted mechanisms of action at the AACR 2023 Annual Meeting, which continues to support our clinical development strategy. NUC
6-K
EX-99.2
NCNA
NuCana plc
15 May 23
Current report (foreign)
4:11pm
EdixoMed and 30 Technology who sold their wound care division to Convatec Group in 2023.
our strategy
strategic report/01
“Our goal is to transform … standards of care and improve survival for patients across a wide range of cancer indications.”
Our strategy includes the following key components
6-K
EX-99.1
2nnt5
15 May 23
Current report (foreign)
4:11pm
6-K
EX-99.1
9bdqgth4v rucwfo7
14 Apr 23
NuCana Presents Data at the AACR 2023 Annual Meeting Highlighting Novel NUC-7738 Mechanisms of Action
8:06am
6-K
EX-99.2
hygevulszegofnao2
16 Nov 22
Unaudited Condensed Consolidated Statements of Operations
4:13pm
6-K
EX-99.1
w0e39vrd7ex8ha2ie sy
26 Oct 22
NuCana Presents Positive Data on NUC-3373 at the 34th EORTC-NCI-AACR Annual Meeting 2022
7:05am
6-K
EX-99.1
lgarui xvtm
12 Sep 22
NuCana Presents Favorable Data on NUC-3373 at the European Society of Medical Oncology (ESMO) Annual Meeting 2022
8:19am
6-K
EX-99.2
asjlpa1utsyba14o
17 Aug 22
Unaudited Condensed Consolidated Statements of Operations
4:06pm
6-K
EX-99.2
qg3 1v3renhxmg5
2 Jun 22
Unaudited Condensed Consolidated Statements of Operations
4:05pm
6-K
EX-99.1
20c974
23 May 22
Notice of 2022 Annual General Meeting
4:05pm
6-K
EX-99.1
k135d5ivzy
27 Apr 22
NuCana Reports Fourth Quarter and Year Ended 2021 Financial Results and Provides Business Update
4:08pm
6-K
EX-99.1
593ip182s xbpp52t
8 Mar 22
NuCana Announces Upcoming Presentations on NUC-3373 at the American Association for Cancer Research (AACR) Annual Meeting 2022
4:45pm
6-K
EX-99.3
6kuqzqln43 dx2
18 Nov 21
Unaudited Condensed Consolidated Statements of Operations
4:11pm
6-K
EX-99.1
3m61wpgu4ag
1 Nov 21
NuCana Appoints Elliott M. Levy, M.D. to its Board of Directors
4:10pm
6-K
EX-99.3
fy5h3cfcqgaudjrsnpy
19 Aug 21
Unaudited Condensed Consolidated Statements of Operations
4:28pm